ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm reports Positive Pre-IND meeting with US FDA
Published: 21/02/20, 08:16am (AEST)•2 pages